Long Island
Capital Alliance Announces Participants for
Biotech
Technology Transfer Capital Forum
Event to be Held on June
14 in Collaboration with Cold Spring Harbor Laboratory
Melville, NY – June
7, 2013
– The Long Island Capital Alliance
(“LICA”),
the leading non-profit capital formation and business development organization
serving regional companies, today announced the presenting companies and
panelists for its Biotech Technology Transfer Capital Forum to be held on June
14, 2013. The capital forum is being held
in collaboration with Cold Spring Harbor Laboratory (“CSHL”) in an effort to facilitate the formation and acceleration
of high-growth businesses on Long Island, based on technologies developed at CSHL.
CSHL
scientists will present some of the exciting new technologies developed there
to biotech investors, and investors will have an opportunity to meet and establish
relationships with the CSHL officials and scientists. Each of the underlying technologies LICA
selected for presentation at the event is believed to represent catalysts for
significant growth which will be attractive to investors and other financial
backers. CSHL is continuing to expand
its outreach and partnerships toward building locally-based companies around its
technologies using the “technology transfer” concept.
Technology transfer
involves the use of inventions, processes, and knowledge developed by subject
matter experts to create and enhance private sector businesses. Technology
transfer involves a wide range of approaches to get technologies to market,
including licensing to larger, more established companies, establishing equity
transactions to provide technology to startup businesses, and entering into
research and development agreements, including Small Business Innovation
Research (SBIR) programs, to collaboratively advance the technology toward
commercialization.
A panel of investors
and technology transfer experts will describe the process of financing and
building companies around technological discoveries.
Biotech
Technology Transfer Capital Forum on June 14, 2013 – Participants
Panel
of Investors
Greg Blake: Mr. Blake founded Brocair Partners in 2004 with a focus on
providing advisory services to healthcare companies on a variety of merger and
acquisition, financing, and strategic matters. Mr. Blake has an exceptional set
of senior-level relationships in the healthcare industry, and has worked with
clients that range from large publicly-traded healthcare companies to small
family-owned businesses.
Larry Chaityn: Larry Chaityn is a Managing Director and Head
of Global Health care Banking at Kaminski Partners, a global investment bank. He
is responsible for overseeing the day-to-day operations of the bank including
deal sourcing, deal review, due diligence investigation and client-facing
operations. He has 14 years of health care/life sciences advisory experience,
is an active member in the venture capital and angel investment communities and
in the National Association of Health Services Executives.
Scott Livingston: Mr. Livingston is the President of Livingston Securities, an
investment banking firm that specializes in the nanotechnology and biosciences
industries. Mr. Livingston has hosted the annual "Livingston
Nanotechnology Conference," Wall Street's largest annual nanotechnology
investor conference, since 2005.
Steve Winick: Steve Winick is a principal of Topspin Partners, one
of Long Island's leading venture capital firms. Steve previously served as CIO
of Honeywell International's $2B security group. He had been with Honeywell
(and the Ademco division of Pittway Corp., before its acquisition
by Honeywell in 2000) for over 21 years as CTO of the security
business, as well as founder and president of its wireless communications
services business.
Presenting
Companies and Technologies
Novel
Treatment for Diabetes, Obesity and Cancer: exploiting an oral dosage of a key regulator of insulin,
leptin and HER2 oncogene function. (Professor Nicholas Tonks, FRS)
RapidCaP: the next generation platform to cure metastatic prostate
cancer. (Professor Lloyd Trotman)
Velocin-N(TM): a new enzyme that enables faster, more sensitive and more
selective detection of proteins (the miniature machines and structures of life)
in mass spectrometers. (Dr. John Wilson)
Wilson
Advanced Research:
develops products with novel health, social and commercial benefit,
spanning a wide range from consumer products to environmental clean-up,
including a simple solution to eliminate the largest reservoir of
bacteria--including MURSA and E. coli 0157-- from homes. (Dr. John Wilson)
LICA,
in collaboration with CSHL, will host the Biotech
Technology Transfer Capital Forum on June 14, 2013 from 8:00 a.m. to 10:30 a.m.
at 68 South Service Road, Melville, NY. The capital forum provides an
opportunity to meet CSHL scientists, industry executives, capital providers,
entrepreneurs, and businesses seeking capital, as well as to hear a panel of
industry experts discuss financing alternatives for biotech technology
transfer-based businesses.
About the Long Island Capital Alliance:
Since 1984, the
Long Island Capital Alliance (www.licapital.org), formerly known as Long Island Venture Group,
has been promoting business growth on
Long Island. LICA seeks to create a productive and business-friendly
environment that will afford area businesses access to the resources necessary
to compete successfully in today's markets. LICA serves as a focal point for
the exchange of ideas among new and existing business enterprises, successful
entrepreneurs, investors, and service providers. Through quarterly capital
forums and special meetings, LICA brings together members of the region's
business community, and has been recognized as the place to turn to when small
businesses need equity, debt, or other financing, or for investors to find an
attractive investment opportunity.
LICA's
mission is to encourage economic development on Long Island by facilitating
capital formation for a broad range of companies in various industries, from
early stage to mature middle market closely held and publicly-traded
businesses. LICA accomplishes this primarily through education, networking,
quarterly capital forums, periodic special educational meetings, and alliances
with other regional organizations. LICA brings together members of the region's
business community and serves as the finance arm for significant local business
and organizations.
About Cold Spring Harbor Laboratory
Founded in 1890, Cold Spring Harbor Laboratory (CSHL) has shaped
contemporary biomedical research and education with programs in cancer, neuroscience,
plant biology and quantitative biology. CSHL is ranked number one in the world
by Thomson Reuters for impact of its research in molecular biology and
genetics. The Laboratory has been home to eight Nobel Prize winners. Today,
CSHL's multidisciplinary scientific community is more than 600 researchers and
technicians strong and its Meetings & Courses program hosts more than
12,000 scientists from around the world each year to its Long Island campus and
its China center. Tens of thousands more benefit from the research, reviews,
and ideas published in journals and books distributed internationally by CSHL
Press. The Laboratory's education arm also includes a graduate school and
programs for undergraduates as well as middle and high school students and
teachers. CSHL is a private, not-for-profit institution on the north shore of
Long Island. For more information, visit www.cshl.edu.
* * *
Contact:
Jordan
Darrow
(631)
367-1866
jdarrow@darrowir.com